Full Paper
9]
4
.4 Hz, 1 H), 8.05 (d, J = 6.0 Hz, 2 H), 7.51–7.44 (m, 3 H), 7.19 (s, 1
2-Phenyl-3-selenocyanatoimidazo[1,2-a]pyridine (7aa):[ Yellow
1
3
1
H), 6.97 (m, 1 H), 2.66 (s, 3 H) ppm. C NMR (101 MHz, CDCl ): δ = solid. H NMR (400 MHz, CDCl ): δ = 8.41 (d, J = 6.8 Hz, 1 H), 7.97–
3
3
1
1
52.5, 148.2, 132.3, 129.3, 128.9, 128.7, 128.5, 126.8, 122.1, 114.4, 7.95 (m, 2 H), 7.71 (d, J = 8.8 Hz, 1 H), 7.52–7.48 (m, 2 H), 7.46–7.40
08.4, 94.8, 16.8 ppm.
(m, 2 H), 7.09–7.05 (m, 1 H) ppm. 13C NMR (101 MHz, CDCl ): δ =
3
1
53.5, 148.5, 132.5, 129.3, 129.1, 128.6, 127.8, 125.5, 118.1, 114.2,
7
(
-Methyl-2-phenyl-3-thiocyanatoimidazo[1,2-a]pyridine
4ad):[ White solid. H NMR (400 MHz, CDCl ): δ = 8.28 (d, J =
9]
1
99.0, 93.6 ppm.
3
7
.2 Hz, 1 H), 8.04 (d, J = 7.2 Hz, 2 H), 7.53–7.43 (m, 4 H), 7.19 (s, 1
1
3
H), 6.92 (d, J = 6.8 Hz, 1 H), 2.46 (s, 3 H) ppm. C NMR (101 MHz,
Acknowledgments
CDCl ): δ = 152.9, 148.3, 139.5, 132.1, 129.3, 128.7, 123.5, 116.9,
3
1
16.7, 108.5, 93.7, 21.5 ppm.
The authors thank the National Natural Science Foundation of
China (grant numbers 21542007, 21076035), the Program for
New Century Excellent Talents in University (NCET-11-0053), and
the Fundamental Research Funds of the Central Universities
6
-Chloro-2-phenyl-3-thiocyanatoimidazo[1,2-a]pyridine
3af):[
10]
1
(
White solid. H NMR (400 MHz, CDCl ): δ = 8.43 (s, 1 H),
3
8
.02 (d, J = 6.8 Hz, 2 H), 7.65 (d, J = 8.8 Hz, 1 H), 7.51–7.38 (m, 4 H)
13
ppm. C NMR (101 MHz, CDCl ): δ = 153.5, 146.3, 131.5, 129.7, (DUT15TD25) for their support of this work.
3
1
29.5, 128.8, 128.7, 122.9, 122.5, 118.6, 107.8, 95.7 ppm.
2
-Phenyl-3-thiocyanato-6-(trifluoromethyl)imidazo[1,2-a]pyr- Keywords: Synthetic methods · Aromatic substitution ·
1
idine (4ag): White solid, m.p. 172.3–174.8 °C. H NMR (400 MHz,
CDCl ): δ = 8.74 (s, 1 H), 8.04 (d, J = 6.8 Hz, 2 H), 7.82 (d, J = 8.8 Hz,
1
Nitrogen heterocycles · Thiocyanates · Sulfur
3
19
H), 7.59 (d, J = 8.8 Hz, 1 H), 7.50 (d, J = 7.2 Hz, 3 H) ppm. F NMR
1
3
(470 MHz, CDCl ): δ = –62.0 (s, 3 F) ppm. C NMR (101 MHz, CDCl3):
[1] a) K. S. Gudmundsson, B. A. Johns, Org. Lett. 2003, 5, 1369–1372; b) C.
Enguehard-Gueiffier, A. Gueiffier, Mini-Rev. Med. Chem. 2007, 7, 888–899;
c) O. N. Burchak, L. Mugherli, M. Ostuni, J. J. Lacapère, M. Y. Balakirev, J.
Am. Chem. Soc. 2011, 133, 10058–10061; d) A. Nordqvist, M. T. Nilsson,
O. Lagerlund, D. Muthas, J. Gising, S. Yahiaoui, L. R. Odell, B. R. Srinivasa,
M. Larhed, S. L. Mowbray, A. Karlén, Med. Chem. Commun. 2012, 3, 620–
626; e) K. Skonieczny, A. I. Ciuciu, E. M. Nichols, V. Hugues, M. Blanchard-
Desce, L. Flamigni, D. T. Gryko, J. Mater. Chem. 2012, 22, 20649–20664;
f) J. Wan, C.-J. Zheng, M.-K. Fung, X.-K. Liu, C.-S. Lee, X.-H. Zhang, J. Mater.
Chem. 2012, 22, 4502–4510; g) S. Nazari, S. Cameron, M. B. Johnson, K.
Ghandi, J. Mater. Chem. A 2013, 1, 11570–11579; h) M. Banasiewicz, I.
Deperasinska, A. Makarewicz, D. Firmansyah, D. T. Gryko, B. Kozankiewicz,
Phys. Chem. Chem. Phys. 2015, 17, 8945–8950.
3
δ = 154.5, 147.8, 131.2, 130.0, 128.9, 128.8, 120.4 (q, J = 273.0 Hz),
1
24.0, 123.3 (q, J = 5.9 Hz), 119.0, 118.9 (q, J = 34.9 Hz), 118.7, 107.4,
+
9
7.1 ppm. HRMS (ESI): calcd. for C H F N S [M + H] 320.0464;
1
5 8 3 3
found 320.0469.
[
9]
6
-Phenyl-5-thiocyanatoimidazo[2,1-b]thiazole (4ah): White
1
solid. H NMR (400 MHz, CDCl ): δ = 7.97 (s, 2 H), 7.64–7.06 (m, 5
3
H) ppm. 13C NMR (101 MHz, CDCl ): δ = 154.4, 153.3, 132.1, 129.2,
3
1
28.8, 128.1, 117.8, 114.8, 108.4, 95.8 ppm.
[
10]
2
-Phenyl-3-thiocyanatobenzo[d]imidazo[2,1-b]thiazole (4ai):
1
White solid. H NMR (400 MHz, CDCl ): δ = 8.45 (d, J = 8.0 Hz, 1 H),
3
7
7
.93 (d, J = 8.0 Hz, 2 H), 7.74 (d, J = 8.0 Hz, 1 H), 7.55–7.42 (m, 2 H),
.02 (d, J = 8.0 Hz, 2 H), 3.91 (s, 3 H) ppm. C NMR (101 MHz,
[2] a) L. Almirante, L. Polo, A. Mugnaini, E. Provinciali, P. Rugarli, A. Biancotti,
A. Gamba, W. Murmann, J. Med. Chem. 1965, 8, 305–312; b) M. H. Fisher,
A. Lusi, J. Med. Chem. 1972, 15, 982–985; c) J. J. Kaminski, A. M. Doweyko,
J. Med. Chem. 1997, 40, 427–436; d) A. Gueiffier, S. Mavel, M. Lhassani,
A. Elhakmaoui, R. Snoeck, G. Andrei, O. Chavignon, J.-C. Teulade, M. Wit-
vrouw, J. Balzarini, E. De Clercq, J.-P. Chapat, J. Med. Chem. 1998, 41,
5108–5112; e) M. A. Ismail, R. Brun, T. Wenzler, F. A. Tanious, W. D. Wilson,
D. W. Boykin, J. Med. Chem. 2004, 47, 3658–3664; f) A. Scribner, R. Dennis,
J. Hong, S. Lee, D. McIntyre, D. Perrey, D. Feng, M. Fisher, M. Wyvratt, P.
Leavitt, P. Liberator, A. Gurnett, C. Brown, J. Mathew, D. Thompson, D.
Schmatz, T. Biftu, Eur. J. Med. Chem. 2007, 42, 1334–1357; g) T. H. Al-Tel,
R. A. Al-Qawasmeh, R. Zaarour, Eur. J. Med. Chem. 2011, 46, 1874–1881.
1
3
CDCl ): δ = 160.5, 155.5, 152.6, 144.1, 132.9, 130.1, 129.7, 126.9,
1
3
25.6, 124.5, 114.2, 113.7, 109.0, 96.9, 55.4 ppm.
2
-Phenyl-3-thiocyanatoimidazo[1,2-a]pyrimidine (4aj): Pale yel-
1
low solid, m.p. 198.2–201.3 °C. H NMR (400 MHz, DMSO): δ = 9.23–
9
.21 (m, 1 H), 8.84–8.82 (m, 1 H), 8.16 (d, J = 7.2 Hz, 2 H), 7.64–7.60
m, 2 H), 7.56–7.53 (m, 1 H), 7.43–7.40 (m, 1 H) ppm. 1 C NMR
3
(
(
101 MHz, DMSO): δ = 153.9, 151.8, 150.1, 134.7, 132.3, 130.0, 129.3,
1
28.9, 111.3, 110.6, 97.5 ppm. HRMS (ESI): calcd. for C H N S [M +
13 8 4
+
H] 253.0542; found 253.0546.
[
[
[
3] a) S. Z. Langer, S. Arbilla, J. Benavides, B. Scatton, Adv. Biochem. Psycho-
pharmacol. 1990, 46, 61; b) R. J. Boerner, H. J. Moller, Psychopharma-
kother. 1997, 4, 145–148; c) K. Mizushige, T. Ueda, K. Yukiiri, H. Suzuki,
Cardiovasc. Drug Rev. 2002, 20, 163–174; d) L. A. Sorbera, J. Castaner,
P. A. Leeson, Drugs Future 2002, 27, 935–941.
2
-(4-Methoxyphenyl)-7-methyl-3-thiocyanatoimidazo[1,2-a]-
[10]
1
pyridine (4dd):
White solid. H NMR (400 MHz, CDCl ): δ = 8.27
3
(d, J = 6.8 Hz, 1 H), 8.01 (d, J = 8.4 Hz, 2 H), 7.47 (s, 1 H), 7.03 (d,
J = 8.4 Hz, 2 H), 6.90 (d, J = 6.8 Hz, 1 H), 3.87 (s, 3 H), 2.46 (s, 3 H)
4] a) A. Douhal, F. Amat-Guerri, A. U. Acuña, J. Phys. Chem. 1995, 99, 76–
ppm. 13C NMR (101 MHz, CDCl ): δ = 160.5, 152.8, 148.2, 139.5,
3
8
0; b) T. Mutai, H. Tomoda, T. Ohkawa, Y. Yabe, K. Araki, Angew. Chem.
1
30.1, 124.5, 123.5, 116.7, 116.5, 114.1, 108.5, 92.8, 55.4, 21.5 ppm.
Int. Ed. 2008, 47, 9522–9524; Angew. Chem. 2008, 120, 9664–9666; c) G.
Song, Y. Zhang, X. Li, Organometallics 2008, 27, 1936–1943; d) A. John,
M. M. Shaikh, P. Ghosh, Dalton Trans. 2009, 10581–10591.
6
-Chloro-2-(4-chlorophenyl)-3-thiocyanatoimidazo[1,2-a]-
[10]
1
pyridine (4ff):
White solid. H NMR (400 MHz, CDCl ): δ = 8.45
3
5] a) S. M. Roopan, S. M. Patil, J. Palaniraja, Res. Chem. Intermed. 2015, 1–
(
s, 1 H), 7.99 (d, J = 8.4 Hz, 2 H), 7.68 (d, J = 9.6 Hz, 1 H), 7.49 (d,
4
8
2; b) K. Pericherla, P. Kaswan, K. Pandey, A. Kumar, Synthesis 2015, 47,
87–912; c) A. K. Bagdi, S. Santra, K. Monir, A. Hajra, Chem. Commun.
1
3
J = 8.4 Hz, 2 H), 7.45–7.43 (m, 1 H) ppm. C NMR (101 MHz, CDCl3):
δ = 152.4, 146.3, 135.9, 130.0, 129.9, 129.7, 129.1, 123.2, 122.4, 118.7,
1
2015, 51, 1555–1575; d) S. Manna, R. Narayan, C. Golz, C. Strohmann,
07.4, 95.7 ppm.
A. P. Antonchick, Chem. Commun. 2015, 51, 6119–6122; e) R. Goel, V.
Luxami, K. Paul, RSC Adv. 2015, 5, 81608–81637.
2
-(3-Bromophenyl)-7-methyl-3-thiocyanatoimidazo[1,2-a]-
[10]
1
[6] a) C. J. Mussinan, M. E. Keelan, Sulphur Compounds in Foods, American
Chemical Society, Washington, DC, 1984, p. 1067–1286; b) A. T. Pham, T.
Ichiba, W. Y. Yoshida, P. J. Scheuer, T. Uchida, J.-I. Tanaka, T. Higa, Tetrahe-
dron Lett. 1991, 32, 4843–4846; c) R. G. Mehta, J. Liu, A. Constantinou,
C. F. Thomas, H. Hawthorne, M. You, C. Gerhäuser, J. M. Pezzuto, R. C.
Moon, R. M. Moriarty, Carcinogenesis 1995, 16, 399–405; d) A. D. Patil,
A. J. Freyer, R. Reichwein, B. Carte, L. B. Killmer, L. Faucette, R. K. Johnson,
pyridine (4hd): Pale yellow solid. H NMR (400 MHz, CDCl ): δ =
8
3
.27 (d, J = 7.2 Hz, 1 H), 8.19 (s, 1 H), 7.98 (d, J = 7.6 Hz, 1 H), 7.55
(d, J = 8.0 Hz, 1 H), 7.47 (s, 1 H), 7.38–7.34 (m, 1 H), 6.94 (d, J =
1
3
6
1
1
.8 Hz, 1 H), 2.47 (s, 3 H) ppm. C NMR (101 MHz, CDCl ): δ = 151.1,
3
48.2, 139.8, 134.1, 132.2, 131.5, 130.2, 127.1, 123.5, 122.9, 117.3,
16.8, 108.0, 94.2, 21.5 ppm.
Eur. J. Org. Chem. 0000, 0–0
www.eurjoc.org
6
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim